Post-earnings recap
Reported
Thu, Apr 24, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Regencell Bioscience Holdings Limited reported an EPS of $0.20, exceeding expectations slightly. However, there was no revenue reported, and no stock reaction is noted. The lack of guidance and management commentary leaves uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.20 | N/A | +2.04% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.